MIAMI, FL / / December 3, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ('Telomir' or the 'Company'), an emerging leader in age-reversal science, today announced groundbreaking preclinical ...
Nov 20, 2024Patients of progeria on average rarely survive into adulthood. A new drug offers hope to the 60 diagnosed patients of the genetic condition in India. Nov 13, 2024England's NHS is ...
Expanding Research and Future Applications Telomir is intensifying its focus on the potential use of Telomir-1 to treat progeria, a rare genetic disorder that causes accelerated aging in children.
MIAMI, FL / ACCESSWIRE / November 21, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), an emerging leader in age-reversal science, today announced groundbreaking ...
Sammy Basso, who has died aged 28, was born with progeria, an extremely rare genetic disorder which causes sufferers to age rapidly and appear older than they are; refusing to give in to despair ...